Roche Holding AG
Cerrado
SectorSanidad
373.2 0.92
Resumen
Variación precio
24h
Mínimo
373.2
Máximo
374.6
Ingresos | 1.4B 6.9B |
|---|---|
Ventas | -208M 30B |
P/B Media del Sector | 23.632 68.51 |
Rentabilidad por dividendo | 2.72 |
Margen de beneficios | 22.629 |
Empleados | 103,249 |
EBITDA | -2.2B 9.4B |
Rentabilidad por dividendo Media del Sector | 2.72% 2.29% |
|---|
Capitalización Mercado | 22B 288B |
|---|---|
Apertura anterior | 372.28 |
Cierre anterior | 373.2 |
Roche Holding AG Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Roche Holding AG previsión
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.